Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K.

Addiction. 2010 Jul;105(7):1254-64. doi: 10.1111/j.1360-0443.2010.02949.x. Epub 2010 May 14.

2.

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).

Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR.

J Urban Health. 2003 Mar;80(1):137-46.

3.

Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA.

PLoS One. 2014 Oct 6;9(10):e109282. doi: 10.1371/journal.pone.0109282. eCollection 2014.

4.

Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.

Evans JL, Morris MD, Yu M, Page K, Hahn JA.

Drug Alcohol Depend. 2014 Sep 1;142:239-44. doi: 10.1016/j.drugalcdep.2014.06.028. Epub 2014 Jul 4.

5.

Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.

Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR.

Hepatology. 2001 Jul;34(1):180-7.

PMID:
11431749
6.

Traveling young injection drug users at high risk for acquisition and transmission of viral infections.

Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):43-50. Epub 2007 Nov 5.

7.

Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.

Kim NJ, Jin H, McFarland W, Raymond HF.

Int J Drug Policy. 2015 Dec;26(12):1238-43. doi: 10.1016/j.drugpo.2015.08.013. Epub 2015 Aug 22.

PMID:
26365768
8.

Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.

Harris M, Rhodes T.

Drug Alcohol Depend. 2013 Oct 1;132(3):617-23. doi: 10.1016/j.drugalcdep.2013.04.012. Epub 2013 May 7.

PMID:
23664125
9.

Risk behaviors for HIV in sexual partnerships of San Francisco injection drug users.

Chen YH, McFarland W, Raymond HF.

AIDS Care. 2014;26(5):554-8. doi: 10.1080/09540121.2013.841840. Epub 2013 Oct 4.

PMID:
24093881
10.

"To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants.

Smith BD, Jewett A, Burt RD, Zibbell JE, Yartel AK, DiNenno E.

J Infect Dis. 2013 Dec 15;208(12):1934-42. doi: 10.1093/infdis/jit520. Epub 2013 Oct 16.

11.

Gender differences in injection risk behaviors at the first injection episode.

Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):145-52. Epub 2007 Feb 5.

PMID:
17276623
12.

Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.

Burt RD, Thiede H, Hagan H.

Drug Alcohol Depend. 2009 Dec 1;105(3):215-20. doi: 10.1016/j.drugalcdep.2009.07.005. Epub 2009 Aug 31.

PMID:
19720473
13.

Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors.

Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):143-9. doi: 10.1016/j.drugalcdep.2012.06.024. Epub 2012 Jul 20.

14.

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M.

Addiction. 2011 Nov;106(11):1978-88. doi: 10.1111/j.1360-0443.2011.03515.x. Epub 2011 Aug 24.

PMID:
21615585
15.

Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.

Bryant J, Brener L, Hull P, Treloar C.

Drug Alcohol Depend. 2010 Mar 1;107(2-3):182-7. doi: 10.1016/j.drugalcdep.2009.10.007. Epub 2009 Nov 25.

PMID:
19942380
16.

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR.

J Infect Dis. 2002 Dec 1;186(11):1558-64. Epub 2002 Nov 4.

18.

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.

Kwiatkowski CF, Fortuin Corsi K, Booth RE.

Addiction. 2002 Oct;97(10):1289-94.

PMID:
12359033
19.

Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics.

Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn JA.

J Urban Health. 2013 Jun;90(3):500-15. doi: 10.1007/s11524-012-9718-2.

20.

HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.

Alipour A, Haghdoost AA, Sajadi L, Zolala F.

Sex Transm Infect. 2013 Nov;89 Suppl 3:iii41-4. doi: 10.1136/sextrans-2013-051201. Epub 2013 Sep 24.

Items per page

Supplemental Content

Write to the Help Desk